| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000008243 |
| Receipt No. | R000009064 |
| Official scientific title of the study | Effect of Helicobacter pyroli eradication on patient with non aclcholic fatty liver disease |
| Date of disclosure of the study information | 2012/06/25 |
| Last modified on | 2018/12/30 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Effect of Helicobacter pyroli eradication on patient with non aclcholic fatty liver disease | |
| Title of the study (Brief title) | HELPER Study2 | |
| Region |
|
|
| Condition | ||||
| Condition | non alcoholic fatty liver disease
Helicobacter pylori infection |
|||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | The purpose of this study is to investigate the effects of Helicobacter pylori eradication on patients with non alcoholic fatty liver disease. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Liver dysfunction at pre and post Helicobacter pylori eradication |
| Key secondary outcomes | Lipid profile and insulin resistance at pre and post Helicobacter pylori eradication |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Helicobacter pylori eradication (Lansoprazole60mg/day, AMPC1500mg/day,CAM800mg/day for 7 days) | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)Patients with non alcoholic fatty liver disease
2)Patients with gastric or duodenal ulcer scar and helicobacter pylori infection |
|||
| Key exclusion criteria | 1)Patients with another liver disease
2)Patients with previous hepatectomy 3)Patients with intiated or changed anitidiabetic, antidyslipidemic, antiinflammatory drugs or liver supporting therapy 4)Patients with severe infection or trauma 5)Patients with malignancy 6)Patients with gastric or duodenal ulcer in the acute phase 7)Patients druing pregnancy or lactation 8)Patients with severe liver dysfunction or renal insufficiency 9)Patients who received steroid therapy 10)Patients who were allergic to Helicobacter pylori eradication drugs 11)Patients who cann not take written informed consent 12)Patients determined to be inappropriate by phyysician |
|||
| Target sample size | 60 | |||
| Research contact person | |
| Name of lead principal investigator | Yasuo Hata |
| Organization | Chigasaki Municipal Hospital |
| Division name | Gastroenterology Division |
| Address | 5-15-1 Honson Chigasaki Kanagawa Japan |
| TEL | 0467-52-1111 |
| Public contact | |
| Name of contact person | Takashi Uchiyama |
| Organization | Chigasaki Municipal Hospital |
| Division name | Gastroenterology Division |
| Address | 5-15-1 Honson Chigasaki Kanagawa Japan |
| TEL | 0467-52-1111 |
| Homepage URL | |
| tuchiyama-ykh@umin.ac.jp | |
| Sponsor | |
| Institute | Chigasaki Municipal Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000009064 |